T1	Participants 37 72	acute coronary syndromes in Canada:
T2	Participants 609 788	patients with acute coronary syndromes and, in addition, patients undergoing percutaneous coronary intervention in the Percutaneous Coronary Intervention in CURE (PCI-CURE) trial.
T3	Participants 854 882	Canadian health care system.
T4	Participants 1646 1659	CURE patients
T5	Participants 1674 1692	PCI-CURE patients.
